Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease

The Alzheimer's disease (AD) epidemic is a looming crisis, with an urgent need for new therapies to delay or prevent symptom onset and progression. There is growing awareness that clinical trials must target stage-appropriate pathophysiological mechanisms to effectively develop disease-modifyin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chalermpalanupap, Termpanit, Kinkead, Becky, Hu, William T, Kummer, Markus P, Hammerschmidt, Thea, Heneka, Michael T, Weinshenker, David, Levey, Allan I
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3706916/
https://ncbi.nlm.nih.gov/pubmed/23634965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt175
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items